Trinity Biotech Plc Appoints Paul D'Agrosa to Enhance Life Sciences Division

Trinity Capital Strengthens Life Sciences Division with New Appointment

Trinity Capital Inc., a leading alternative asset manager based in Phoenix, Arizona, makes a significant move to enhance its Life Sciences division by appointing Paul D'Agrosa as Managing Director. This strategic decision comes as the company seeks to broaden its influence in the Life Sciences sector across new U.S. markets. D'Agrosa, who operates from Denver, Colorado, brings over a decade of specialized experience in loan origination and business development, positioning him to play a crucial role in advancing Trinity's objectives in this rapidly evolving industry.

In his previous role at Horizon Technology Finance, D'Agrosa successfully supervised the Western U.S. Healthcare and Life Sciences sector, where he originated more than $140 million in loan commitments. His focus encompassed critical areas such as Medtech, Healthtech, Biotech, and Diagnostics/Tools, underscoring his capability to identify and nurture opportunities in the Life Sciences arena. Before joining Horizon, D'Agrosa spent ten years at Silicon Valley Bank, where he gained extensive insights and established key relationships within the industry. His diverse background equips him with a unique perspective that Trinity Capital intends to leverage for strategic growth.

Rob Lake, Senior Managing Director of Life Sciences at Trinity, expresses strong confidence in D'Agrosa's appointment, praising his proven track record and extensive industry connections. Lake notes that D'Agrosa’s expertise aligns perfectly with Trinity's mission to support innovative companies that are transforming the Life Sciences sector. D'Agrosa himself conveys enthusiasm for his new role, emphasizing Trinity’s rapid growth and his commitment to driving progress within the industry. With a history of deploying over $4.7 billion across more than 420 investments since its establishment in 2008, Trinity Capital is well-positioned to utilize D'Agrosa's skills to enhance its tailored debt solutions for growth-oriented companies.

In addition to D'Agrosa's appointment, Trinity Capital's strategy continues to focus on delivering consistent returns through access to private credit markets across various lending verticals. This includes Sponsor Finance, Equipment Finance, Tech Lending, Asset-Based Lending, and Life Sciences. The company’s dedication to fostering innovation and growth in the Life Sciences sector, coupled with D'Agrosa's leadership, signals a promising future for both Trinity Capital and the companies it partners with.

Overall, Trinity Capital's recent developments reflect a deeper commitment to expanding its Life Sciences platform, reinforcing its status as a trusted partner for companies seeking tailored financing solutions within this dynamic industry landscape.